Cytori Therapeutics ( CYTX) develops, manufactures, and sells medical products and devices to enable the practice of regenerative medicine. Cytori's technology is the Celuion family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. This stock is trading up 3% at $2.59 in recent trading. Today's Range: $2.50-$2.65 52-Week Range: $1.90-$5.72 Volume: 136,000 Three-Month Average Volume: 333,892 >>5 Stocks Under $10 Set to Soar From a technical perspective, CYTX is moving notably higher here on light volume as the stock bounces off some near-term support at $2.40. This move is quickly pushing CYTX within range of triggering a near-term breakout trade. That trade will hit once CYTX takes out some near-term overhead resistance at $2.60, and then its 200-day moving average of $2.71 with high volume. Traders should now look for long-biased trades if CYTX can sustain a move or close above those levels with volume that's near or above 333,892 shares. If we get that action today or soon, then look for CYTX to possibly re-test and take out its next significant overhead resistance levels at just over $3.20 to $3.45. Traders should make note of the fact that this stock is currently trending above its 50-day at $2.29, which is bullish price action. To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.